About Par Biosciences Private Limited
Data last updated:
Par Biosciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Par Formulations Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 15 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24233TN2012PTC086326. Its GSTIN is 33AADCE0757C1Z6 (Tamil Nadu).
The company has an authorised share capital of ₹6.01 Cr and a paid-up capital of ₹5.71 Cr. It was formerly known as Ethics Bio Lab Private Limited. It is led by directors including James Matthew Papp and Chitti Babu Sampath Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9/215 Pudupakkam Vandalur Main Road Pudupakkam Kelambakkam, Chennai, Tamil Nadu, India – 603103.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.31 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹1.86 Cr (net margin 56.2%) and EBITDA of ₹3.05 Cr (EBITDA margin 92%). Revenue has declined at a compounded annual rate (CAGR) of 55% over three years and 33% over five years.
The company has about 39 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹10.89 Cr on record. The company has 3 deals on record (1 funding round, 1 acquisition, 1 secondary share transfer), with disclosed funding of ₹8.04 Cr; the latest was in January 2015. Its 10 peer companies in the Outsourcing industry (Accounting and Financial Analysis, Biosciences, Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Vyome Therapeutics Limited with revenue of ₹3.35 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 6 overdue payments to 4 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website parpharm.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address9/215 Pudupakkam Vandalur Main Road Pudupakkam Kelambakkam, Chennai, Tamil Nadu, India – 603103
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Par Biosciences Private Limited
The main business activity of Par Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Par Biosciences Private Limited FY 2025 filings available
Par Biosciences Private Limited reported revenue of ₹3.31 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Par Biosciences Private Limited
Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 33%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Par Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.05 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.86 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Par Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 56.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Par Biosciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Par Biosciences Private Limited
Par Biosciences has 3 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| James Matthew Papp Also directs: Par Active Technologies Private Limited | Director | 28 Jan 2021 | 5 Years 8 Months | Current |
| Chitti Babu Sampath Kumar | Director | 28 Jun 2017 | 9 Years 3 Months | Current |
| Anand Amrit Raj | Director | 27 May 2022 | 4 Years 4 Months | Current |
Peer Comparison of Par Biosciences Private Limited
Par Biosciences Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Accounting and Financial Analysis, Biosciences, Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vyome Therapeutics Limited | ₹3.35 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Vadodara, Gujarat, India |
| Crowe Advisory Services (India) Private Limited | ₹3.33 Cr (FY 2018) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
| Zucol Solutions Private Limited | ₹3.32 Cr (FY 2023) | •••• | •••• | 7.0% | •••• | Jaipur, Rajasthan, India |
| K R Financial and Management Service Pvt Ltd | ₹3.31 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Genpop Consumer Research Private Limited | ₹3.31 Cr (FY 2018) | •••• | •••• | 121.0% | •••• | Bangalore, Karnataka, India |
| Par Biosciences Private Limited this company | ₹3.31 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Chennai, Tamil Nadu, India |
| Venus Accountants Private Limited | ₹3.29 Cr (FY 2025) | •••• | •••• | 70.0% | •••• | Ahmedabad, Gujarat, India |
| Futuresys Technologies Private Limited | ₹3.29 Cr (FY 2023) | •••• | •••• | -2.0% | •••• | Jaipur, Rajasthan, India |
| Centre of Human Reproduction and Biosciences Private Limited | ₹3.29 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Bangalore, Karnataka, India |
| GMK Research Laboratories Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Secunderabad, Telangana, India |
| Mediception Science Private Limited | ₹3.27 Cr (FY 2024) | •••• | •••• | 35.0% | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Par Biosciences by revenue in the Outsourcing industry (Accounting and Financial Analysis, Biosciences, Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Par Biosciences Private Limited
Par Biosciences Private Limited is audited by Price Waterhouse & Co Chartered Accountants LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Price Waterhouse & Co Chartered Accountants LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Par Biosciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Par Biosciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2022 | Others | ₹25 Lakh | Satisfied |
| 19 Dec 2012 | State Bank of India | ₹10.64 Cr | Satisfied |
Total charge records: 2 View all charges
Deals & Funding of Par Biosciences Private Limited
Par Biosciences Private Limited has 3 deals on record (1 funding round, 1 acquisition, 1 secondary share transfer), with disclosed funding of ₹8.04 Cr; the latest was in January 2015.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2015 | Funding round | ₹8.04 Cr | Investors: Par Formulations Private Limited |
| Jan 2015 | Acquisition | ₹57.62 Cr | Buyer: Par Formulations Private Limited Seller: Clan Laboratories Private Limited , 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Par Biosciences Private Limited
Par Biosciences Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 6 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Par Biosciences Private Limited
Par Biosciences Private Limited has a workforce of 39 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Par Biosciences Private Limited
Par Biosciences Private Limited has 18 board changes on record since 2015: 3 appointments and 15 cessations. The latest: Anand Amrit Raj ceased to be Additional Director on 30 Sep 2022.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Par Biosciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Par Biosciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Par Biosciences Private Limited
Par Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCE0757C1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Par Biosciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Par Biosciences Private Limited
Par Biosciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 15 June 2012 (14+ years old) and is registered under CIN U24233TN2012PTC086326.
Par Biosciences reported revenue of ₹3.31 Cr for FY 2025 (up 1% YoY).
Par Biosciences has 3 current directors:
- James Matthew Papp - Director
- Chitti Babu Sampath Kumar - Director
- Anand Amrit Raj - Director
Par Biosciences reported a net profit of ₹1.86 Cr (net margin 56.2%) and EBITDA of ₹3.05 Cr (EBITDA margin 92%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Par Biosciences is -55% over three years and -33% over five years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Par Biosciences is 33AADCE0757C1Z6, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Par Biosciences is U24233TN2012PTC086326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Par Biosciences was incorporated on 15 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
Par Biosciences has 3 deals on record (1 funding round, 1 acquisition, 1 secondary share transfer), with disclosed funding of ₹8.04 Cr; the latest was in January 2015.
The peers of Par Biosciences by revenue are Vyome Therapeutics Limited, Crowe Advisory Services (India) Private Limited, Zucol Solutions Private Limited, K R Financial and Management Service Pvt Ltd, Genpop Consumer Research Private Limited and 5 more, all in the Outsourcing industry (Accounting and Financial Analysis, Biosciences, Contract Research).
Anand Amrit Raj ceased to be Additional Director on 30 Sep 2022. Anand Amrit Raj was appointed as Director on 27 May 2022. Jalaj Sharma ceased to be Director on 27 May 2022. Par Biosciences has 18 board changes on record in total.
Par Biosciences has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 6 overdue payments to 4 micro and small suppliers. The latest return was filed on 30 Oct 2021.